Discussion on Pharmac’s funding criteria
New Zealanders are being asked to share their views on how Pharmac, the government’s medicine funding agency, makes its decisions surrounding drug funding.
A public forum will be held in Mt Albert next week as part of a nationwide review of the agency’s decision-making criteria.
Critical to the debate will be whether certain patients with life-threatening health issues are granted access to expensive but potentially life-restoring medications.
Chief executive Steffan Crausaz says Pharmac has used the criteria for nearly 20 years and it is essential the services the agency provides reflect the preferences of the community to the best extent possible.
‘‘Pharmac’s work has changed and expanded since the decision criteria were first put in place.
‘‘There may be some additional things that people think are important for us to take into account when we are making decisions about pharmaceutical funding.’’
One group urging Kiwis to have a say is the Paroxysmal Nocturnal Haemoglobinuria support association which is seeking funding for the lifesaving drug Soliris. The drug treats the rare and fatal blood disorder.
The forum is at the Mt Albert War Memorial Hall on June 25 from 10.45am to 1pm.
Submissions regarding Soliris are open for public response until July 31.